Chronic Lymphocytic Leukemia (CLL): Minimal Residual Disease as a Surrogate Endpoint for Clinical Trials

February 27, 2013

Name

Organization

Title

Address

City

State

Zip

Email Address

I will attend in-person at the FDA White Oak Campus.

I will participate by webcast.

Workshop Location:

FDA White Oak Campus
Building 31
The Great Room (Rm. 1503)
White Oak Conference Center
10903 New Hampshire Avenue
Silver Spring, Maryland